Cogent Biosciences, Inc. (COGT)

37.29 -1.60 (-4.11%) USD  |  NASDAQ  |  Mar 03, 11:52
More

Cogent Biosciences Stock Based Compensation (5 Year Growth)

Stock Based Compensation (5 Year Growth) Chart

View Stock Based Compensation (5 Year Growth) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (5 Year Growth) Range, Past 5 Years

View Stock Based Compensation (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (5 Year Growth) Benchmarks

View Stock Based Compensation (5 Year Growth) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Sarepta Therapeutics, Inc. --
BridgeBio Pharma, Inc. Upgrade
Olema Pharmaceuticals, Inc. --
Revolution Medicines, Inc. Upgrade